Rate of permanent cardiac implantable electronic device infections after active fixation temporary transvenous pacing: A nationwide Danish cohort study

[1]  C. Israel,et al.  [2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)]. , 2022, Giornale italiano di cardiologia.

[2]  M. Pombo,et al.  Comments on the 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. , 2022, Revista espanola de cardiologia.

[3]  Jay A. Montgomery,et al.  Staphylococcus bacteremia without evidence of a cardiac implantable electronic device infection. , 2020, Heart rhythm.

[4]  M. Hernán,et al.  Why Test for Proportional Hazards? , 2020, JAMA.

[5]  S. Kutalek,et al.  Outcomes of Standard Permanent Active Fixation Leads for Temporary Pacing. , 2020, JACC. Clinical electrophysiology.

[6]  G. Boriani,et al.  European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS) , 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  S. Eid,et al.  Complications and Outcomes of Temporary Transvenous Pacing: An Analysis of > 360,000 Patients From the National Inpatient Sample , 2019, Chest.

[8]  D. Brieger,et al.  Outcomes of 4838 patients requiring temporary transvenous cardiac pacing: A statewide cohort study. , 2018, International journal of cardiology.

[9]  L. Køber,et al.  Cardiac implantable electronic device and associated risk of infective endocarditis in patients undergoing aortic valve replacement , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  L. Pedersen,et al.  Positive predictive value of infective endocarditis in the Danish National Patient Registry: a validation study , 2018, Epidemiology and Infection.

[11]  M. Shoda,et al.  2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. , 2017, Heart rhythm.

[12]  H. Bøtker,et al.  Positive predictive value of cardiac examination, procedure and surgery codes in the Danish National Patient Registry: a population-based validation study , 2016, BMJ Open.

[13]  H. Bøtker,et al.  Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study , 2016, BMJ Open.

[14]  H. Sørensen,et al.  Data Resource Profile: The Danish National Prescription Registry , 2016, International journal of epidemiology.

[15]  E. Stuart,et al.  Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies , 2015, Statistics in medicine.

[16]  M. Falagas,et al.  Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[17]  D. Krummen,et al.  Utility and safety of temporary pacing using active fixation leads and externalized re-usable permanent pacemakers after lead extraction. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[18]  J. Castaneda,et al.  Lower incidence of venous thrombosis with temporary active-fixation lead implantation in mobile patients. , 2010 .

[19]  Jacques Victor,et al.  Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators: Results of a Large Prospective Study , 2007, Circulation.

[20]  U. Kappert,et al.  Percutaneous Lead Implantation Connected to an External Device in Stimulation‐Dependent Patients with Systemic Infection—A Prospective and Controlled Study , 2006, Pacing and clinical electrophysiology : PACE.

[21]  J. Avorn,et al.  Variable selection for propensity score models. , 2006, American journal of epidemiology.

[22]  C. Visser,et al.  Utility and Safety of Prolonged Temporary Transvenous Pacing Using an Active‐Fixation Lead: , 2003, Pacing and clinical electrophysiology : PACE.

[23]  C. Visser,et al.  Usefulness of a New Active‐Fixation Lead in Transvenous Temporary Pacing from the Femoral Approach , 2003, Pacing and clinical electrophysiology : PACE.

[24]  P. Sanders,et al.  Effect of anticoagulation on the occurrence of deep venous thrombosis associated with temporary transvenous femoral pacemakers. , 2001, The American journal of cardiology.